| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |